Metraipolis › archive › dc_80eb7be508ff

Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of… — Europe PMC PMID:41473225

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41473225
DOI: 10.3389/fneur.2025.1715748
License (as archived): solo-consultazione
Archived: 2026-11-07T15:53:23.241Z
SHA-256 of the archived text: 2a8cd3946123a1d16f8ebbac2370e16074fa1f06b2007d7589a7e6c67f2c040e
Stable URL of this page: https://metraipolis.com/documento/dc_80eb7be508ff

How to cite

Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of… — Europe PMC PMID:41473225 — Europe PMC (en), https://europepmc.org/article/MED/41473225 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80eb7be508ff (Metraipolis archive dc_80eb7be508ff, sha256 2a8cd3946123a1d16f8ebbac2370e16074fa1f06b2007d7589a7e6c67f2c040e)

BibTeX

@misc{dc80eb7be508ff,
  title = {Early start of opicapone in Parkinson's disease: evidence from a pooled analysis of phase 3 trials for sustained benefit in patients with recent onset of… — Europe PMC PMID:41473225},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41473225},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80eb7be508ff; sha256 2a8cd3946123a1d16f8ebbac2370e16074fa1f06b2007d7589a7e6c67f2c040e},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41473225. Agents can read the archived copy with the MCP tool read_document.